World's Best Scientists 2026 revealed!
Véronique Leblond

Véronique Leblond

D-Index & Metrics

Medicine

D-Index
87
Citations
26732
World Ranking
13688
National Ranking
439

Overview

Véronique Leblond is affiliated with Sorbonne University in France and has contributed extensively to the field of medicine, with a specific focus on hematology and oncology. Their research portfolio includes a significant number of publications addressing aspects of lymphoma, leukemia, immunology, and molecular genetics.

Their recent research work features several key papers, including:

  • A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study (2020) in Blood
  • Consensus treatment recommendations from the tenth International Workshop for Waldenström Macroglobulinaemia (2020) in The Lancet Haematology
  • Ibrutinib Plus Rituximab Versus Placebo Plus Rituximab for Waldenström's Macroglobulinemia: Final Analysis From the Randomized Phase III iNNOVATE Study (2021) in Journal of Clinical Oncology
  • Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study (2023) in Journal of Clinical Oncology
  • Zanubrutinib for the treatment of MYD88 wild-type Waldenström macroglobulinemia: a substudy of the phase 3 ASPEN trial (2020) in Blood Advances

Their frequent co-authors include Damien Roos-Weil, Christian Buske, Meletios Α. Dimopoulos, Alessandra Tedeschi, and Caroline Dartigeas.

Véronique Leblond has published mostly in:

  • Blood
  • Journal of Clinical Oncology
  • Blood Advances
  • Leukemia
  • Haematologica

The main field of study is Medicine, with subfields that include:

  • Genetics
  • Pathology and Forensic Medicine
  • Immunology
  • Oncology
  • Hematology

Their research covers topics such as:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Immunodeficiency and Autoimmune Disorders
  • Chronic Myeloid Leukemia Treatments
  • Gastrointestinal Tumor Research and Treatment
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment

Best Publications

  • High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial.

    Jean-Paul Fermand;Philippe Ravaud;Sylvie Chevret;Marine Divine

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.

    Arnaud Jaccard;Philippe Moreau;Véronique Leblond;Xavier Leleu

  • High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

    Jean-Paul Fermand;Sandrine Katsahian;Marine Divine;Veronique Leblond

  • Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study

    Sylvain Choquet;Veronique Leblond;Raoul Herbrecht;Gérard Socié

  • Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.

    Enric Carreras;Hartmut Bertz;William Arcese;Jean-Paul Vernant

  • Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients

    Karim Belhadj;Felix Reyes;Jean-Pierre Farcet;Herve Tilly

  • International prognostic scoring system for Waldenstrom macroglobulinemia

    Pierre Morel;Alain Duhamel;Paolo Gobbi;Meletios A. Dimopoulos

  • Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

    Ralf Trappe;Stephan Oertel;Veronique Leblond;Peter Mollee

  • Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients

    N. Milpied;B. Vasseur;N. Parquet;J. L. Garnier

  • Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

    Robert A. Kyle;Steven P. Treon;Raymond Alexanian;Bart Barlogie

  • Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.

    D. Maraninchi;D. Blaise;B. Rio;V. Leblond

  • Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma

    Hongtao Ye;Hongxiang Liu;Ayoma Attygalle;Andrew C. Wotherspoon

  • Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue for Refractory and Recurrent Primary CNS and Intraocular Lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire

    Carole Soussain;Khê Hoang-Xuan;Luc Taillandier;Emmanuelle Fourme

  • A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

    Constantine S. Tam;Stephen Opat;Shirley D'Sa;Wojciech Jurczak

  • Results of Intensive Chemotherapy Followed by Hematopoietic Stem-Cell Rescue in 22 Patients With Refractory or Recurrent Primary CNS Lymphoma or Intraocular Lymphoma

    Carole Soussain;Florence Suzan;Khê Hoang-Xuan;Nathalie Cassoux

  • Anti–B-Cell Monoclonal Antibody Treatment of Severe Posttransplant B-Lymphoproliferative Disorder: Prognostic Factors and Long-Term Outcome

    Malika Benkerrou;Jean-Philippe Jais;Véronique Leblond;Anne Durandy

  • Phase 3 Trial of Ibrutinib plus Rituximab in Waldenström’s Macroglobulinemia

    Meletios A. Dimopoulos;Alessandra Tedeschi;Judith Trotman;Ramón García-Sanz

  • Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients

    Philippe Moreau;Véronique Leblond;Priscille Bourquelot;Thierry Facon

  • Post-transplant lymphoproliferative disorders

    Vikas R Dharnidharka;Angela C Webster;Olivia M Martinez;Jutta K Preiksaitis

Frequent Co-Authors

Frederic Davi
Frederic Davi Assistance Publique – Hôpitaux de Paris
Steven P. Treon
Steven P. Treon Harvard University
Meletios A. Dimopoulos
Meletios A. Dimopoulos National and Kapodistrian University of Athens
Olivier Hermine
Olivier Hermine Necker-Enfants Malades Hospital
Christian Buske
Christian Buske University of Ulm
Stephan Stilgenbauer
Stephan Stilgenbauer University of Ulm
Frédéric Charlotte
Frédéric Charlotte Université Paris Cité
Ramón García-Sanz
Ramón García-Sanz University of Salamanca
Sylvie Chevret
Sylvie Chevret Université Paris Cité
Efstathios Kastritis
Efstathios Kastritis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers a wide range of online degrees and certifications, providing flexible pathways for those interested in healthcare careers. For students not ready to commit to full medical school, an accessible entry point is a medical coding certification. These programs can quickly prepare you for roles in administrative healthcare, with the potential for career growth.

Aspiring nurses can also find affordable options. For example, cheap online fnp programs allow registered nurses to advance their qualifications and become Family Nurse Practitioners without compromising their work schedules. Those just starting their nursing journey can consider online nursing school as a flexible and budget-friendly way to earn their degree and enter the healthcare workforce.

For professionals aiming to contribute to nursing education and research, doctorate in nursing education online programs provide a flexible, advanced pathway to leadership roles. These online opportunities make it easier than ever to join the medical field or advance your career while balancing other commitments.

Best Scientists Citing Véronique Leblond

Trending Scientists